Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
12%
ALSO IN MEDX
MEDX
27
HOLDINGS
22%
ALSO IN IHE
SECTOR DRIFT (IHE minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.6% | 18.5% | 18.5% |
|
JOHNSON & JOHNSON | 20.8% | 5.4% | 5.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 4.7% | 4.1% |
|
MERCK & CO. INC. | 4.5% | 4.0% | 4.0% |
|
PFIZER INC | 4.1% | 3.3% | 3.3% |
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 15.4% |
|
ELI LILLY & CO | 6.1% |
|
ROYALTY PHARMA PLC CLASS A | 5.2% |
|
VIATRIS, INC. | 4.6% |
 |
JAZZ PHARMACEUTICALS PLC | 3.8% |
|
ELANCO ANIMAL HEALTH, INC. | 3.1% |
|
ZOETIS INC | 2.9% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
|
CORCEPT THERAPEUTICS INC | 1.8% |
|
LIGAND PHARMACEUTICALS-CL B | 1.2% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -8.5% |
 |
NOVARTIS AG-ADR | -7.0% |
 |
ASTRAZENECA PLC | -5.2% |
|
ALKERMES PLC | -4.8% |
|
IONIS PHARMACEUTICALS, INC. | -4.5% |
|
AMGEN INC | -4.0% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
BIOGEN IDEC INC | -3.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
CRISPR THERAPEUTICS AG | -2.7% |